The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
申请公布号
EP2525812(B1)
申请公布日期
2017.01.18
申请号
EP20110703410
申请日期
2011.01.20
申请人
Boehringer Ingelheim International GmbH
发明人
VAN RYN, Joanne;PARK, John Edward;HAUEL, Norbert;KUNZ, Ulrich;LITZENBURGER, Tobias;CANADA, Keith;SINGH, Sanjaya;WATERMAN, Alisa
